These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 8383638

  • 1. Effects of dexfenfluramine treatment on body weight and postprandial thermogenesis in obese subjects. A double-blind placebo-controlled study.
    Lafreniere F, Lambert J, Rasio E, Serri O.
    Int J Obes Relat Metab Disord; 1993 Jan; 17(1):25-30. PubMed ID: 8383638
    [Abstract] [Full Text] [Related]

  • 2. Dexfenfluramine treatment of obesity: a double blind trial with post trial follow up.
    O'Connor HT, Richman RM, Steinbeck KS, Caterson ID.
    Int J Obes Relat Metab Disord; 1995 Mar; 19(3):181-9. PubMed ID: 7780494
    [Abstract] [Full Text] [Related]

  • 3. Dexfenfluramine reduces cardiovascular risk factors.
    Bremer JM, Scott RS, Lintott CJ.
    Int J Obes Relat Metab Disord; 1994 Apr; 18(4):199-205. PubMed ID: 8044193
    [Abstract] [Full Text] [Related]

  • 4. The effect of dexfenfluramine on eating habits in a Dutch ambulatory android overweight population with an overconsumption of snacks.
    Drent ML, Zelissen PM, Koppeschaar HP, Nieuwenhuyzen Kruseman AC, Lutterman JA, van der Veen EA.
    Int J Obes Relat Metab Disord; 1995 May; 19(5):299-304. PubMed ID: 7647820
    [Abstract] [Full Text] [Related]

  • 5. The acute effect of dexfenfluramine on resting metabolic rate and postprandial thermogenesis in obese subjects: a double-blind placebo-controlled study.
    Scalfi L, D'Arrigo E, Carandente V, Coltorti A, Contaldo F.
    Int J Obes Relat Metab Disord; 1993 Feb; 17(2):91-6. PubMed ID: 8384170
    [Abstract] [Full Text] [Related]

  • 6. Dexfenfluramine as an adjunct to a reduced-fat, ad libitum diet: effects on body composition, nutrient intake and cardiovascular risk factors.
    Swinburn BA, Carmichael HE, Wilson MR.
    Int J Obes Relat Metab Disord; 1996 Nov; 20(11):1033-40. PubMed ID: 8923161
    [Abstract] [Full Text] [Related]

  • 7. Dexfenfluramine in obese Chinese NIDDM patients. A placebo-controlled investigation of the effects on body weight, glycemic control, and cardiovascular risk factors.
    Chow CC, Ko GT, Tsang LW, Yeung VT, Chan JC, Cockram CS.
    Diabetes Care; 1997 Jul; 20(7):1122-7. PubMed ID: 9203448
    [Abstract] [Full Text] [Related]

  • 8. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.
    Eliasson B, Gudbjörnsdottir S, Cederholm J, Liang Y, Vercruysse F, Smith U.
    Int J Obes (Lond); 2007 Jul; 31(7):1140-7. PubMed ID: 17264849
    [Abstract] [Full Text] [Related]

  • 9. Long-term changes of body weight and cardiovascular risk factors after weight reduction with group therapy and dexfenfluramine.
    Pfohl M, Luft D, Blomberg I, Schmülling RM.
    Int J Obes Relat Metab Disord; 1994 Jun; 18(6):391-5. PubMed ID: 8081430
    [Abstract] [Full Text] [Related]

  • 10. Effect of dexfenfluramine on body weight, blood pressure, insulin resistance and serum cholesterol in obese individuals.
    Holdaway IM, Wallace E, Westbrooke L, Gamble G.
    Int J Obes Relat Metab Disord; 1995 Oct; 19(10):749-51. PubMed ID: 8589769
    [Abstract] [Full Text] [Related]

  • 11. The effects of dexfenfluramine on weight loss and cardiovascular risk factors in female patients with upper and lower body obesity.
    Ditschuneit HH, Flechtner-Mors M, Adler G.
    J Cardiovasc Risk; 1996 Aug; 3(4):397-403. PubMed ID: 8946272
    [Abstract] [Full Text] [Related]

  • 12. The effect of long-term dexfenfluramine treatment on 24-hour energy expenditure in man. A double-blind placebo controlled study.
    Breum L, Astrup A, Andersen T, Lammert O, Nielsen E, Garby L, Quaade F.
    Int J Obes; 1990 Jul; 14(7):613-21. PubMed ID: 2228396
    [Abstract] [Full Text] [Related]

  • 13. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice.
    Breum L, Pedersen JK, Ahlstrøm F, Frimodt-Møller J.
    Int J Obes Relat Metab Disord; 1994 Feb; 18(2):99-103. PubMed ID: 8148931
    [Abstract] [Full Text] [Related]

  • 14. [Effect of dexfenfluramine on eating behavior and body weight of obese patients: results of a field study of Isomeride in Austrian general practice].
    Geyer G, Haidinger G, Francesconi M, Langmayr N, Prager R, Schoberberger R, Toplak H, von Kalckreuth G, Kunze M.
    Acta Med Austriaca; 1995 Feb; 22(5):95-101; 104-9. PubMed ID: 8651045
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of dexfenfluramine in obese patients: a multicenter study.
    Enzi G, Crepaldi G, Inelmen EM, Bruni R, Baggio B.
    Clin Neuropharmacol; 1988 Feb; 11 Suppl 1():S173-8. PubMed ID: 3052815
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of dexfenfluramine in a weight loss program for obese infertile women.
    Galletly C, Clark A, Tomlinson L.
    Int J Eat Disord; 1996 Mar; 19(2):209-12. PubMed ID: 8932560
    [Abstract] [Full Text] [Related]

  • 17. Prolonged surveillance of dexfenfluramine in severe obesity.
    Mathus-Vliegen EM.
    Neth J Med; 1993 Dec; 43(5-6):246-53. PubMed ID: 8107932
    [Abstract] [Full Text] [Related]

  • 18. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
    Muls E, Kolanowski J, Scheen A, Van Gaal L, ObelHyx Study Group.
    Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
    [Abstract] [Full Text] [Related]

  • 19. Effects of dexfenfluramine on resting metabolic rate and thermogenesis in premenopausal obese women during therapeutic weight reduction.
    Van Gaal LF, Vansant GA, Steijaert MC, De Leeuw IH.
    Metabolism; 1995 Feb; 44(2 Suppl 2):42-5. PubMed ID: 7869937
    [Abstract] [Full Text] [Related]

  • 20. Postprandial thermogenesis in post-obese women and weight-matched controls.
    Bukkens SG, McNeill G, Smith JS, Morrison DC.
    Int J Obes; 1991 Feb; 15(2):147-54. PubMed ID: 2040551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.